143096-38-2

Upstream product

• 2835-95-2 amino-4 hydroxy-2 toluene 
• 1374139-09-9 methyl 6-bromo-3-(dibromomethyl)-2-methoxybenzoate 
• 143096-37-1 methyl 6-bromo-2-methoxy-3-methylbenzoate 
• 143096-36-0 methyl 6-amino-2-methoxy-3-methylbenzoate 
• 143096-35-9 6-[(2,2-dimethyl-1-oxopropyl)amino]-2-methoxy-3-methylbenzoic acid 
• 143096-34-8 N-(3-methoxy-4-methylphenyl)-2,2-dimethylpropanamide 

Downstream Products

• 1374139-15-7 methyl 6-[2-(benzyloxy)-6-(hydroxymethyl)-4-methylphenoxy]-3-formyl-2-methoxybenzoate 
• 1374139-16-8 6-[2-(benzyloxy)-6-(hydroxymethyl)-4-methylphenoxy]-3-formyl-2-methoxybenzoic acid 
• 1374139-17-9 11-(benzyloxy)-4-methoxy-9-methyl-5-oxo-5,7-dihydrodibenzo-[b,g][1,5]-dioxocine-3-carbaldehyde 
• 1374139-18-0 11-(benzyloxy)-3-(1-hydroxy-3-methylbut-3-en-1-yl)-4-methoxy-9-methyl-5H,7H-dibenzo[b,g][1,5]-dioxocin-5-one 
• 1438868-23-5 methyl 6-(2-(benzyloxy)-4-(ethylthio)-6-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)phenoxy)-3-formyl-2-methoxybenzoate 
• 1438868-20-2 methyl 6-(2-(benzyloxy)-4-(methylthio)-6-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)phenoxy)-3-formyl-2-methoxybenzoate 
• 1435935-56-0 methyl 6-((3-(benzyloxy)-4'-methoxy-5-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-[1,1'-biphenyl]-4-yl)oxy)-3-formyl-2-methoxybenzoate 
• 689224-94-0 methyl 6-(2-(benzyloxy)-6-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)phenoxy)-3-formyl-2-methoxybenzoate 

Relevant academic research and scientific papers

A convergent approach to dibenzodioxocinones: Synthesis of racemic penicillide

A convergent approach to dibenzodioxocinones was explored, thereby racemic penicillide ((±)-1a) could be obtained in 13 steps in 4.2% overall yield, based on 5-amino-2-methylphenol (5) (Schemes 2-4).

Substituted dibenz-oxa-thiocinones, -12-oxides and -12,12-dioxides, a process for their preparation and their use in medicaments

The invention relates to substituted dibenz-oxa-thiocinone-12-oxides and -12,12-dioxides of the general formula I STR1 in which R1 to R6 and Y have the meaning indicated in the description, to processes for their preparation and to their use in medicaments, in particular in circulation-influencing medicaments.